From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: in 100% defence of Roger Lawson of ShareSoc

By Tom Winnifrith | Tuesday 19 May 2020


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I start by thanking both Jim Mellon and Nigel Wray who have eached pledged £1000 to Rogue bloggers for Woodlarks, ahead of June 13 when I shall be walking around my fields here in Wales. Woodlarks needs £48,000 to survive the year. We have now raised 17% of that, please can you make a donation, however small, today to get us closer to target. Please give HERE. I then launch into a heartfelt defence of Roger Lawson of Sharesoc over what appears to be an undeclared related party deal at the organisation that campaigns for improved corporate governance and transparency. Then I look at Imperial Brands (IMB) and First Derivatives (FDP), one a stonking long the other a stonking short.

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 10:03:38